Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Winston E. Abara"'
Autor:
Winston E. Abara, Kyle T. Bernstein, Felicia M.T. Lewis, Preeti Pathela, Aras Islam, Michael Eberhart, Iris Cheng, Alexandra Ternier, Jennifer Sanderson Slutsker, Robbie Madera, Robert Kirkcaldy
Publikováno v:
Sexually Transmitted Diseases. 50:e8-e10
Autor:
Winston E Abara, Kyle T Bernstein, Felicia M T Lewis, Julia A Schillinger, Kristen Feemster, Preeti Pathela, Susan Hariri, Aras Islam, Michael Eberhart, Iris Cheng, Alexandra Ternier, Jennifer Sanderson Slutsker, Sarah Mbaeyi, Robbie Madera, Robert D Kirkcaldy
Publikováno v:
Lancet Infect Dis
BACKGROUND: Declining antimicrobial susceptibility to current gonorrhoea antibiotic treatment and inadequate treatment options have raised the possibility of untreatable gonorrhoea. New prevention approaches, such as vaccination, are needed. Outer me
Autor:
Winston E. Abara, Patrick Sullivan, Tom Carpino, Travis Sanchez, Kait Atkins, Kevin Delaney, O. Winslow Edwards, Hannah Marissa, Stefan Baral, Yasmin Ogale, Eboni Galloway, Amy Lansky
Publikováno v:
Sexually Transmitted Diseases.
Autor:
Anne M. Hause, James Baggs, Paige Marquez, Winston E. Abara, Babatunde Olubajo, Tanya R. Myers, John R. Su, Deborah Thompson, Julianne Gee, Tom T. Shimabukuro, David K. Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:347-351
Publikováno v:
The Journal of Infectious Diseases. 225:1569-1574
Using meta-analytic methods, we calculated expected rates of 20 potential adverse events of special interest (AESI) that would occur after coronavirus disease 2019 (COVID-19) vaccination within 1-, 7-, and 42-day intervals without causal associations
Autor:
Tom T. Shimabukuro, Anne M. Hause, Paige Marquez, Charles Licata, Deborah Thompson, Winston E. Abara, James Baggs, Hannah G. Rosenblum, Tanya R. Myers, David K. Shay, Julianne Gee, John R. Su
Publikováno v:
Morbidity and Mortality Weekly Report
As of July 30, 2021, among the three COVID-19 vaccines authorized for use in the United States, only the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine is authorized for adolescents aged 12-17 years. The Food and Drug Administration (FDA) issued an E
Autor:
Anne M. Hause, David K. Shay, Nicola P. Klein, Winston E. Abara, James Baggs, Margaret M. Cortese, Bruce Fireman, Julianne Gee, Jason M. Glanz, Kristin Goddard, Kayla E. Hanson, Brandon Hugueley, Tat’Yana Kenigsberg, Elyse O. Kharbanda, Bruno Lewin, Ned Lewis, Paige Marquez, Tanya Myers, Allison Naleway, Jennifer C. Nelson, John R. Su, Deborah Thompson, Babatunde Olubajo, Matthew E. Oster, Eric S. Weintraub, Joshua T.B. Williams, Anna R. Yousaf, Ousseny Zerbo, Bicheng Zhang, Tom T. Shimabukuro
Publikováno v:
Pediatrics
BACKGROUND AND OBJECTIVES Limited postauthorization safety data for the Pfizer-BioNTech coronavirus disease 2019 vaccination among children ages 5 to 11 years are available, particularly for the adverse event myocarditis, which has been detected in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d720eaa8a2f2faabeb7b0d7d391276
https://europepmc.org/articles/PMC9706403/
https://europepmc.org/articles/PMC9706403/
Autor:
Anne M. Hause, James Baggs, Paige Marquez, Winston E. Abara, Jane Gwira Baumblatt, Deborah Thompson, John R. Su, Tanya R. Myers, Julianne Gee, Tom T. Shimabukuro, David K. Shay
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(28)
Persons with moderate to severe immunocompromising conditions are at risk for severe COVID-19, and their immune response to COVID-19 vaccination might not be as robust as the response in persons who are not immunocompromised* (1). The Advisory Commit
Autor:
Winston E. Abara, Julianne Gee, Paige Marquez, Jared Woo, Tanya R. Myers, Allison DeSantis, Jane A. G. Baumblatt, Emily Jane Woo, Deborah Thompson, Narayan Nair, John R. Su, Tom T. Shimabukuro, David K. Shay
Publikováno v:
JAMA Network Open. 6:e2253845
ImportanceBecause of historical associations between vaccines and Guillain-Barré syndrome (GBS), the condition was a prespecified adverse event of special interest for COVID-19 vaccine monitoring.ObjectiveTo evaluate GBS reports to the Vaccine Adver